
Sign up to save your podcasts
Or
Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies like a sickle cell treatment heading to human trials, and why they built internal AI tools for 25,000+ employees. Learn more at ai-podcast.nvidia.com.
4.5
319319 ratings
Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies like a sickle cell treatment heading to human trials, and why they built internal AI tools for 25,000+ employees. Learn more at ai-podcast.nvidia.com.
159 Listeners
435 Listeners
298 Listeners
151 Listeners
183 Listeners
298 Listeners
105 Listeners
143 Listeners
67 Listeners
201 Listeners
496 Listeners
94 Listeners
43 Listeners
29 Listeners
44 Listeners